AVOID — earned weight 0 of 1.00, the summed measured record of the backing engines.
Because. 32% above fair value
Evidence. fair_value (weight 0.00)
Risk. stop-loss 125.70 (6.8% below the close). Most holdings here lose money within 5-10 sessions — exit at the stop.
The case against. strongest reason to stay out: 32% above fair value. A cheap share can keep falling.
The alternative. WAIT. Doing nothing is usually right — no engine currently has a proven edge on this share.
Base rate. about 1 in 4 liquid PSX shares touches +10% within 10 sessions anyway (25.87%, n=54,955 observations, 2017-2026). ZEME only recommends action when an engine has beaten that in its own record.
Measured from 140 completed Watching runs in ZEME's recorded phase history — these are frequencies of what actually happened next, not forecasts:
Typical stay in this phase: 3 sessions (median). durations are censored: the phase record begins 2026-07-16, so runs that started earlier or are still open are not measured here
ZEME publishes the case against its own signals, and the base rate any share has to beat. Educational analysis, not investment advice.
| Price | Rs 134.82 |
| ZEME fair value | Rs 91.55 |
| Discount to fair value | -32.1% |
| Smart-money phase | Watching |
| Confidence score | 26/100 |
| RSI (14) | 51.5 |
| P/E | 20.1 |
| ROE | 12.2% |
| Dividend yield | —% |
| 52-week range | Rs 124.00 – Rs 177.99 |
| Sector | Pharmaceuticals |
| Shariah-compliant | Yes ☪ |
BFBIO (BF Biosciences Ltd) trades at Rs 134.82 on the Pakistan Stock Exchange, in the Watching smart-money phase — neutral. ZEME's model puts fair value near Rs 91.55, making it about 32.1% overvalued. No decisive smart-money footprint yet — one to watch, not chase.
ZEME AI reads BFBIO through operator accumulation/distribution phases, fair value across three methods, RSI and volume, plus institutional flow (FIPI/LIPI & off-market) — the same smart-money engine behind our daily PSX signals. For the live chart, entry/stop/target and history, open the interactive analysis above.
Neutral — no decisive smart-money signal yet; better setups may exist. No decisive smart-money footprint yet — one to watch, not chase. As of 27 Aug 2026, BFBIO is in the Watching phase with a ZEME confidence score of 26/100.
ZEME estimates BFBIO's fair value at about Rs 91.55, versus a market price of Rs 134.82 — roughly 32.1% overvalued.
BFBIO is currently in the Watching phase. No decisive smart-money footprint yet — one to watch, not chase.
Data updated 27 Aug 2026 from ZEME AI's PSX engine. Educational analytics, not investment advice — do your own research and use a stop loss. Trading carries risk.